PortfoliosLab logo

Benitec Biopharma Inc. (BNTC)

Equity · Currency in USD · Last updated Aug 13, 2022

Company Info

ISINUS08205P1003
CUSIP08205P100
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.85
Year Range$0.74 - $4.26
EMA (50)$1.02
EMA (200)$1.99
Average Volume$2.79M
Market Capitalization$6.97M

BNTCShare Price Chart


Chart placeholderClick Calculate to get results

BNTCPerformance

The chart shows the growth of $10,000 invested in Benitec Biopharma Inc. in Jun 2014 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $26 for a total return of roughly -99.74%. All prices are adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%MarchAprilMayJuneJulyAugust
-69.05%
-2.76%
BNTC (Benitec Biopharma Inc.)
Benchmark (^GSPC)

BNTCReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-24.56%12.08%
6M-70.30%-4.97%
YTD-67.46%-10.20%
1Y-78.31%-3.65%
5Y-52.18%10.56%
10Y-53.35%9.71%

BNTCMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-6.49%-5.31%0.65%-35.76%-30.00%10.48%-22.50%-5.17%
202133.67%-21.45%64.13%-17.41%10.30%-9.77%-17.65%13.14%-9.85%2.52%-16.39%-14.38%
2020-10.39%13.35%-24.13%54.37%-19.78%8.36%-9.73%-2.51%-9.78%-57.17%10.04%1.35%
2019-7.05%29.82%8.29%2.04%-20.00%-53.19%13.50%-15.27%-1.32%-6.79%-18.64%-5.38%
201822.30%-18.51%7.94%-17.72%3.07%-24.82%48.24%-3.73%-16.55%0.04%-13.12%-27.18%
201712.42%56.40%2.60%-7.25%-12.89%-17.04%22.16%-9.29%5.85%31.34%1.75%2.07%
2016-10.70%-57.94%13.25%-13.44%-2.71%-11.94%34.70%6.56%-23.08%6.26%-1.19%4.08%
2015-23.29%11.61%-9.80%1.92%1.82%-15.33%27.39%-41.07%-22.77%-2.93%-25.33%-9.81%
2014-3.18%-14.34%-1.42%-4.06%-45.03%26.23%28.09%

BNTCSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Benitec Biopharma Inc. Sharpe ratio is -0.75. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00MarchAprilMayJuneJulyAugust
-0.75
-0.20
BNTC (Benitec Biopharma Inc.)
Benchmark (^GSPC)

BNTCDividend History

Benitec Biopharma Inc. granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to $0.00 per share.


PeriodTTM20212020201920182017201620152014
Dividend$0.00$0.00$0.00$0.00$0.04$0.00$0.00$0.00$0.00

Dividend yield

0.00%0.00%0.00%0.00%0.20%0.00%0.00%0.00%0.00%

BNTCDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-99.74%
-10.77%
BNTC (Benitec Biopharma Inc.)
Benchmark (^GSPC)

BNTCWorst Drawdowns

The table below shows the maximum drawdowns of the Benitec Biopharma Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Benitec Biopharma Inc. is 99.78%, recorded on Jun 23, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.78%Jun 26, 20141934Jun 23, 2022

BNTCVolatility Chart

Current Benitec Biopharma Inc. volatility is 101.80%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%100.00%200.00%300.00%400.00%MarchAprilMayJuneJulyAugust
101.80%
16.68%
BNTC (Benitec Biopharma Inc.)
Benchmark (^GSPC)